Basel life sciences sector is the most productive in the world
No other life sciences hub in the world is growing as rapidly as the Basel Region, which recorded growth of +9.3 percent per year in the period from 2010 to 2020. In terms of productivity, too, the Basel Region is steaming ahead of the international competition. These are findings from the “Pharmaceutical Hub Switzerland 2022 - Basel Region” report published by Interpharma.
In terms of productivity in the life sciences in Switzerland, the Basel Region is far ahead of the other leading benchmark locations such as the San Francisco Bay Area, Øresund, which straddles the border between Sweden and Denmark, and Singapore. While the Basel life sciences industry generated 526 US dollars per hour worked in 2020, the equivalent value for the San Francisco Bay Area was around 280 US dollars.
The Basel Region is growing faster than any other life sciences ecosystem worldwide: In the period from 2010 to 2020, it recorded annual growth of +9.3 percent. Per job, the life sciences sector generates nearly seven times the average value added of other Basel industries. These are just some of the insights delivered by the 38-page Pharmaceutical Hub Switzerland 2022 – Basel Region report that has now been published by Interpharma, the association of Switzerland’s research-based pharmaceutical industry.
The report also touches on the number of patent applications per million inhabitants, a metric which again reflects the innovative capacity of the life sciences firms based in Basel. In 2018, the relevant figure for Basel was 205. This puts the Basel Region in second place in an international comparison behind Boston. By way of comparison, Munich registered a score of 50, and Paris 35.
The regional universities rank 5 percent above the average for the regions in Western Europe and the USA in the BAK University Index in the CWTS Leiden Ranking. A wealth of highly qualified specialists also represents a competitive and innovative advantage when it comes, for example, to new companies settling in the Basel Region with the support of the investment and innovation promotion agency Basel Area Business & Innovation. In addition, no other major life sciences ecosystem has lower corporate tax rates.
Share this article
You may also be interested in
Evolva launches new line for manufacturers of personal care products
Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...Read More
Record figure for startups in the Basel Area
Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...Read More
Noema Pharma raises 103 million Swiss francs from investors
Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....Read More
Why CDMO companies choose the Basel Area as their location
Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...Read More
Basel still the most attractive small city for business in Europe
As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...Read More
Ariceum Therapeutics establishes subsidiary in Basel
The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...Read More